To date, numerous markers with possible prognostic value have been described, such as/including cytokine levels, tumor cell antigens, delayed-type hypersensitivity reactions, PD-L1 expression, or tumor mutational load (TMB), with the last two biomarkers being particularly relevant. Here, CD274 is linked to neoplasm.